News
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Zomedica launches two new assays for TRUFORMA Platform - canine NT-proBNP and progesterone tests for dogs. These assays provide precise in-clinic results for cardiac and reproductive conditions -
COMMUNIQUÉ DE PRESSE
NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
NanoViricides, Inc. announces that its antiviral drug candidate NV-387 shows promise in combating potential bird flu pandemic. The drug mimics essential host-side features, making it hard for the virus to escape -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Mayr-Melnhof Karton AG: Mayr-Melnhof Karton Aktiengesellschaft decides on share repurchase programme
Mayr-Melnhof Karton AG to repurchase 1,000,000 shares as part of share buyback program starting on 3 January 2025. Company aims to buy back up to 5% of share capital at prices between EUR 10 to EUR 80 per share -
COMMUNIQUÉ DE PRESSE
Exasol secures additional contracts from the financial sector and achieves its planned growth target for 2024
Exasol secures additional contracts from the financial sector and achieves its planned growth target for 2024. The company expands revenue with customers from the financial sector, including a large German state bank for real-time reporting -
-
COMMUNIQUÉ DE PRESSE
VINCI remporte un contrat de modernisation et d’extension d’une station de traitement des eaux à Canberra en Australie
VINCI remporte un contrat de modernisation et d’extension d’une station de traitement des eaux à Canberra en Australie. Le projet inclut une augmentation de la capacité et des mesures environnementales -